why choose us

First received: February 28, 2023

Clinical Trial: TAD After Chemotherapy in Locally Advanced Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sentinel Lymph Node

Study Type: OBSERVATIONAL


Official Title: Target Axillary Dissection After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Brief Summary: This is an observational study to validate target axillary dissection (TAD) in locally advanced tumors (cN2 and/or cT4).

Read more